Investigating the Role of Gut-Derived Neurotoxin TMAO in PTSD Risk Following Traumatic Brain Injury

Area of Science:

• Neuroscience
• Metabolomics
• Psychiatry

Background:

• Post-traumatic stress disorder (PTSD) frequently co-occurs with traumatic brain injury (TBI), significantly impacting patient mood.
• Trimethylamine N-oxide (TMAO), an intestinal flora metabolite, shows a strong correlation with TBI.
• Investigating TMAO's role in TBI-related PTSD is crucial for understanding disease mechanisms.

Purpose of the Study:

• To explore the role of TMAO in the development of TBI-related PTSD.
• To assess the predictive significance of TMAO for PTSD in TBI patients.
• To evaluate TMAO's association with PTSD severity.

Main Methods:

• Included 120 TBI patients, categorizing them into PTSD and non-PTSD groups.
• Assessed serum TMAO levels and correlated them with PTSD incidence and severity.
• Utilized logistic regression and ROC curve analysis to identify risk factors and evaluate TMAO's diagnostic effectiveness.

Main Results:

• Higher serum TMAO levels were significantly associated with PTSD and increased PTSD severity.
• Female gender, lower income, depression, and anxiety were risk factors for PTSD.
• TMAO demonstrated a sensitivity of 67.86% and specificity of 93.75% for predicting PTSD (AUC=0.8175).

Conclusions:

• Serum TMAO levels are elevated in TBI patients with PTSD and correlate with severity.
• TMAO shows potential as a biomarker for early identification of high-risk PTSD patients post-TBI.
• Optimizing intervention strategies for TBI-related PTSD may benefit from TMAO assessment.